Analyst Ratings for Valeant Pharmaceuticals (vrx)

vrx Rating Summary

vrx Price Target Summary

* Over Last 12-Mos
  |   Expand Research on vrx
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $27.53 (+86.9%) * Over Last 12-Mos
Rating Score: 3.8 / 10   Percentile Rank: 40%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
12/15/2016 Morgan Stanley Downgrade Equalweight
(Overweight)
17.00
(25.00)
14.12 14.73 4.32% Details
11/23/2016 Mizuho Securities
» Updated 1/10/2017
Downgrade Underperform
(Neutral)
11.00
(N/A)
17.83 14.73 -17.39% Details
Like VRX Ratings? Also take a look at PRGO, AGN, ENDP, WBA

VRX Ratings News